Market revenue in 2023 | USD 21.1 million |
Market revenue in 2030 | USD 42.8 million |
Growth rate | 10.7% (CAGR from 2023 to 2030) |
Largest segment | Transbronchial needle aspiration (tbna) needles |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 66.35% in 2023. Horizon Databook has segmented the Japan bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The bronchial biopsy devices market in Japan is expected to experience steady growth, driven by ongoing investments in healthcare infrastructure, increasing prevalence of respiratory diseases, and advancements in medical technology.
Major hospitals and medical institutions across Japan are equipped with the latest technologies. For instance, Keio University Hospital in Tokyo is renowned for its integration of cutting-edge medical technologies, including state-of-the-art bronchial biopsy devices.
Moreover, the rising prevalence of respiratory diseases, including COPD and lung cancer, driven by factors such as smoking and an aging population, is expected to drive the demand for effective diagnostic tools, including bronchial biopsy devices. As per the data published by World Cancer Research Fund International, around 136,723 new cases of lung cancer were detected in 2022.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into Japan bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account